SCHEMBL23948727

SCHEMBL23948727

c1ccc(-n2c3ccccc3c3c2c2nc4c5cccnc5c5cccnc5n4c2c2c4ccccc4n(-c4ccccc4)c32)cc1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 7/20 0.40
PDE4B Q07343 6/20 0.40
PDE4C Q08493 6/20 0.40
PDE4D Q08499 6/20 0.40
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
PDE1A P54750 1/20 0.36
PDE1B Q01064 1/20 0.36
KDM4E B2RXH2 2/20 0.36
FEN1 P39748 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ACHE P22303 1/20 0.34
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23948635 0.93 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL23948724 0.83 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL23948655 0.83 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL24768875 0.81 KDM4E (0.46) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL23948650 0.80 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL24290713 0.78 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL24290854 0.78 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL16546935 0.75 KDM4E (0.46) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL24291748 0.75 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL24290542 0.75 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure TEAD4, TEAD2, TEAD1 PDE4A 948/4885PDE4B 1213/4885PDE4C 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.